Video

Dr. Hofstatter on Identifying High-Risk Patients in Breast Cancer

Erin Wysong Hofstatter, MD, associate professor, co-director, Cancer Genetics and Prevention Program, Yale Cancer Center, discusses the important factors for identifying potentially high-risk patients in breast cancer.

Erin Wysong Hofstatter, MD, associate professor, co-director, Cancer Genetics and Prevention Program, Yale Cancer Center, discusses the important factors for identifying potentially high-risk patients in breast cancer.

Getting a diagnosis at an early age is one "red flag," says Hofstatter. If a patient is diagnosed under the age of 50, a physician should consider recommending cancer genetic counseling and potentially genetic testing. Moreover, even if a healthy, unaffected patient has a first-, second-, or third-degree relative who was diagnosed with breast cancer before the age of 50, genetic counseling and/or testing would be highly recommended for that patient as well.

Clustering of certain cancers within one family is another important potential indicator of high-risk disease, even if they appear to be completely unrelated to breast cancer. Thus, gathering an extended three-generation pedigree can be extremely important when it comes to diagnosing breast cancer.

Related Videos
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD
Jonathan Wesley Riess, MD, MS, an associate professor at the University of California (UC) Davis
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Laura A. Huppert, MD
Polly Niravath, MD
Arvind N. Dasari, MD, MS
Charles E. Geyer, Jr., MD
Sattva S. Neelapu, MD